dr. middleton on a bispecific immunotherapy for the treatment of melanoma
Published 9 years ago • 322 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
19:59
professor mark middleton - from chemotherapy to immunotherapy
-
26:27
advanced melanoma treatment landscape: bispecific therapies
-
1:27
dr. kluger on how immunotherapies are changing the treatment of melanoma
-
27:01
immunotherapy for advanced melanoma
-
29:22
immunotherapy: pd-1 antibodies and beyond- dr. carvajal melanoma education symposium 2014
-
30:34
melanoma and immunotherapy with dr. margaret callahan and sharon belvin
-
23:13
bispecific antibodies in multiple myeloma | dana-farber cancer institute
-
6:39
systemic treatment for advanced non-melanoma skin cancer
-
10:42
what is new in melanoma?
-
0:54
rationale for the strong response to immunotherapy in melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
2:11
bispecific antibodies enable synthetic agonistic receptor t-cell therapy in melanoma
-
6:35
the benefits of bispecific antibodies for treating multiple myeloma
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
4:25
the phenomenon of immunotherapy in melanoma
-
1:26
moffitt medical minute (ep. 43) - bispecific antibodies (bsabs) in cancer treatment
-
45:42
what you need to know about bispecific antibody immunotherapy
-
4:26
what are bispecific antibodies?
-
5:44
bispecific antibodies: early side effects